Healthcare

Why is Alterity Therapeutics (ASX:ATH) in news?

HREC has approved Alterity Therapeutics to conduct phase 2 clinical trials of the ATH434 agent in Australia. Following the approval, the price of Alte...

PolyNovo (ASX:PNV) sees its first-ever AU$5M sales month

PolyNovo witnessed its first-ever AU$5.4 million sales month (September 2022). As per the company’s FY2022 results, PolyNovo has increased its revenue...

A flick through Australia’s oral health plan and dental stocks from...

SDI Limited and Pacific Smiles Group are two of the dental care stocks from ASX.

Why has CSL (ASX:CSL) been in news recently?

CSL Limited (ASX:CSL) announced the list of seven awardees that would receive AU$5M over two years to gear up their medical researches.

Opyl (ASX:OPL) collabs with Consentic, launches research screening s...

Opyl has collaborated with e-consent platform, Consentic, for tipping up enrolment and recruitment revenues. The company has also launched a new perso...

Ramsay (ASX:RHC) ends takeover talks with KKR consortium

Shares of Ramsay dropped on Monday morning after the company shared that it has ended takeover discussions.

How these healthcare stocks have fared this quarter

CAU, HMD, ACW are some of the ASX listed healthcare stocks that have outperformed the healthcare index and provided more than 35% price returns this q...

What is latest from these seven ASX telehealth stocks?

ALC, RAP, MDR, ONE, PCK and DOC are some the healthcare stocks from ASX that specialise in telehealth services.

Four ASX healthcare stocks with over 90% gains in past 52 weeks

NEU, AVR, NTI and CTE are some of the ASX-listed healthcare stocks with over 90% price returns in the last 52 weeks.

How are CSL (ASX:CSL) shares performing on YTD basis?

Shares of CSL Limited (ASX:CSL) opened in red today despite no price-sensitive news released by the group.

ASX-listed healthcare giants in focus today

The health care sector was the worst performing sector on ASX today. Let us see how the ASX-listed healthcare companies are faring today.

Ramsay (ASX:RHC) ends talks on IHH's acquisition proposal

Ramsay concludes all discussion on IHH's proposed acquisition.

Healthia (ASX:HLA) calls for a trading halt today, here’s why

Know why Healthia puts its securities under trading halt until Monday.

How are CSL (ASX:CSL) shares performing on ASX?

Shares of CSL Limited (ASX:CSL) have dropped by 0.31% per share today despite no price-sensitive news released by the group.

AFT Pharma (ASX:AFP) to initiate further studies on Maxigesic IV

AFT Pharmaceuticals will conduct additional studies related to Maxigesic IV's packaging before filing for the US FDA registration.

Kalkine : Fisher & Paykel (ASX:FPH) to buy land in Auckland for AU$2...

Fisher & Paykel has signed an agreement to buy a second New Zealand campus.

From JTL, to SHG, AYA: How are these healthtech stocks faring on ASX...

JTL, OAK, GLH, SHG, and AYA are ASX-listed health tech stocks that were on investor’s radar in August.

Mesoblast’s (ASX:MSB) net loss falls to US$91.3M in FY22

Share price of Mesoblast Limited (ASX:MSB) marked a gain after the company reported a fall in loss after tax.

Ramsay (ASX:RHC) records rise in FY22 revenues; requests trading hal...

Ramsay reported total revenues of AU$13,740 million, a 3.1% rise over the previous corresponding period (pcp).

Up 19% in five days, what’s driving Invex’s (ASX:IXC) share price?

shares of Invex registered a gain of 15% in last five trading session following an update released by the company on ASX.